Metastatic bladder cancer immunotherapy outcomes better with antihistamines, study shows

by

Renal + Urology News highlighted research led by the University of Cincinnati’s Alberto Martini, MD, that found using antihistamines in patients receiving second-line immunotherapy (IO) for bladder cancer may improve outcomes.

Leave A Comment

Your email address will not be published. Required fields are marked *